The association between MEF2C (Myocyte Enhancer Factor 2C) and 5q14.3 Microdeletion Syndrome is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording pathogenic variants.
Sources3
Clinical variants1
Symptoms26
Compounds0
Trials0
Publications3
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.